Clinical Trial Update: Levetiracetam for the Treatment of Alcohol Dependence and Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial update for levetiracetam in treating alcohol dependence and anxiety disorders; results completed with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders
• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alcoholism, Generalized Anxiety Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-09-15